• Mashup Score: 2
    VJHemOnc – The video journal of hematological oncology - 3 year(s) ago

    The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve the awareness and understanding of hematological cancers

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      Thank you to our #IMW2021 experts for such an insightful workshop! Want to catch up on our exclusive interviews with experts? Visit 👉https://t.co/O9p0vDBrzw👈 and keep following @VJHemOnc for the latest 💻 @Myeloma_Society #HemOnc #Myeloma #MultipleMyeloma #MMsm https://t.co/VUhR2hQliJ

  • Mashup Score: 2
    CAR-T vs bispecifics: the best immune approach to replace ASCT - 3 year(s) ago

    Hermann Einsele, MD, FRCP, of the University of Würzburg, Würzburg, Germany, shares his thoughts on which method would be most…

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      CAR-T or BsAbs, what is the best immune approach to replace ASCT? 👨‍⚕️ Watch Hermann Einsele of @Uni_WUE discuss both approaches, weighing the pros and cons ⚖️ Watch here 👉https://t.co/mKnkimORO0👈 @VJHemOnc @Myeloma_Society #IMW2021 #MultipleMyeloma #MMsm #HemOnc

  • Mashup Score: 0
    Treatment-free intervals: what is best for patients? - 3 year(s) ago

    Phil McCarthy, MD, of the Roswell Park Comprehensive Cancer Center, Buffalo, NY, talks on the advantages an limitations of giving…

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      💡 Can we give our patients treatment-free intervals for multiple #Myeloma? Watch @PLMcCarthyMD of @RoswellPark as he discusses the pros and cons ⚖️ 🎥 Watch: https://t.co/qwFgbUxpPk @VJHemOnc @Myeloma_Society #IMW2021 #MultipleMyeloma #MMsm #HemOnc

  • Mashup Score: 1
    Novel targets, therapies and combinations for myeloma - 3 year(s) ago

    Enrique Ocio, MD, PhD, of Marqués de Valdecilla University Hospital, Santander, Spain, speaks on novel targets, therapies, and combinations for…

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      💭What are some of the novel targets, therapies, and combinations for #Myeloma? 💻 Watch @OcioEnrique of @HUnivValdecilla as he gives us an update: https://t.co/WAm9dyRd0Q @VJHemOnc @Myeloma_Society #IMW2021 #IMW21 #MultipleMyeloma #MMsm #HemOnc

  • Mashup Score: 0
    Replacing ASCT: CAR-T or bispecific antibodies? - 3 year(s) ago

    Parameswaran Hari, MD, MRCP, MS, of the Froedtert Hospital Cancer Center, Milwaukee, WI, discusses whether chimeric antigen receptor T-cell (CAR-T)…

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      CAR-T vs bispecific antibodies ⚖️ Parameswaran Hari of @Froedtert shares his thoughts on which method would be most beneficial as a replacement for ASCT 👨‍⚕️📣 🎥 Watch here: https://t.co/RHu4EzLGd9 @VJHemOnc @Myeloma_Society #IMW2021 #Myeloma #MultipleMyeloma #MMsm #HemOnc

  • Mashup Score: 0
    The effects of Covid-19 on myeloma patients - 3 year(s) ago

    Heinz Ludwig, MD, of the Wilhelminen Cancer Research Institute, Wilhelminenspital, Vienna, Austria, explains the challenges caused by the COVID-19 pandemic…

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      Heinz Ludwig of the Wilhelminen Cancer Research Institute talks on the effects of the COVID-19 pandemic on #Myeloma patients 👨‍⚕️📣 🎥 Watch the video interview here: https://t.co/mgG2MgT2Cd @VJHemOnc @Myeloma_Society #IMW2021 #MultipleMyeloma #MMsm #HemOnc

  • Mashup Score: 9
    IMW 2021 | VJHemOnc - 3 year(s) ago

    08–11 September 2021 | Vienna, Austria The 18th International Myeloma Workshop (IMW) will be held in Vienna, Austria, as well as online as a virtual event, from September 8-11, 2021. The IMW meeting brings together leading experts in the field of multiple myeloma to present the latest research in the field, from the identification of potential new myeloma drug targets to updates from key…

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      Is stratification based on genomics ready for primetime? @DrGarethMorgan1 discusses! ⁩ Check out our #IMW2021 content: 👉https://t.co/etr3ekTX0E👈 #IMW21 @Myeloma_Society #MMsm #MultipleMyeloma #Myeloma https://t.co/6bdyxcW5Pe

    • Profile photo of VJHemOnc
      VJHemOnc

      Should every transplant-eligible patient with #Myeloma receive a transplant? ⁦A Fantastic debate with @sgiraltbmtdoc and @MorieGertz! ⁦ ⁩ Check out our #IMW2021 content: 👉https://t.co/etr3ekTX0E👈 #IMW21 @Myeloma_Society #MMsm #MultipleMyeloma https://t.co/wkGriZ3EdQ

Load More